Drugs / herbal compound
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06336993 | Jan 2022 → Jun 2023 | — | Zhejiang Provincial Tongde Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | herbal compound | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06336993 ↗ |
| Known as | BSTL | “composition of herbal compound of BSTL was BaiShao 9g, ChuanNiuXi 15g, DanShen 15g, DiLong 9g, DuHuo 9g, DuZhong 15g, GouJi 15g, QinJiao 9g, SangJiSheng 15g, XiXianCao 9g,...” NCT06336993 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Traditional Chinese Herbal Compound as Complementary Treatment” NCT06336993 ↗ |